Search Results - Emmanuel Raffoux

Refine Results
  1. 1

    Contribution of paranasal sinus, chest, and abdomen/pelvis computed tomography in patients with febrile neutropenia. by Charles Tran, Éric de Kerviler, Anne Bergeron, Emmanuel Raffoux, Aliénor Xhaard, Cédric de Bazelaire, Constance de Margerie-Mellon

    Published in PLoS ONE (2025-01-01)
    Get full text
    Article


  2. 2

    Contribution of paranasal sinus, chest, and abdomen/pelvis computed tomography in patients with febrile neutropenia by Charles Tran, Éric de Kerviler, Anne Bergeron, Emmanuel Raffoux, Aliénor Xhaard, Cédric de Bazelaire, Constance de Margerie-Mellon

    Published in PLoS ONE (2025-01-01)
    Get full text
    Article


  3. 3

    Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia by Alexis Talbot, Régis Peffault de Latour, Emmanuel Raffoux, Nimrod Buchbinder, Stéphane Vigouroux, Noel Milpied, Thierry Leblanc, Jean Soulier, Mauricette Michallet, Gérard Socié

    Published in Haematologica (2014-10-01)
    Get full text
    Article


  4. 4

    Impact of post-remission therapy in patients aged 65–70 years with de novo acute myeloid leukemia: a comparison of two concomitant randomized ALFA trials with overlapping age inclu... by Raphael Itzykson, Claude Gardin, Cécile Pautas, Xavier Thomas, Pascal Turlure, Emmanuel Raffoux, Christine Terré, Pierre Fenaux, Sylvie Castaigne, Hervé Dombret, Nicolas Boissel

    Published in Haematologica (2011-06-01)
    Get full text
    Article


  5. 5

    Cartridge-based automated BCR-ABL1 mRNA quantification: solving the issues of standardization, at what cost? by Jean-Michel Cayuela, Elizabeth Macintyre, Meryl Darlington, Raouf Ben Abdelali, Xavier Fund, Patrick Villarese, Michel Tulliez, Emmanuel Raffoux, François Sigaux, Delphine Réa, Valerie Seror

    Published in Haematologica (2011-05-01)
    Get full text
    Article


  6. 6

    Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complications. by Sofiane Fodil, Sylvie Chevret, Camille Rouzaud, Sandrine Valade, Florence Rabian, Eric Mariotte, Emmanuel Raffoux, Raphael Itzykson, Nicolas Boissel, Marie Sébert, Lionel Adès, Lara Zafrani, Elie Azoulay, Etienne Lengliné

    Published in PLoS ONE (2022-01-01)
    Get full text
    Article


  7. 7

    NPM1 mutation is not associated with prolonged complete remission in acute myeloid leukemia patients treated with hypomethylating agents by Pedro Henrique Prata, Cécile Bally, Thomas Prebet, Christian Recher, Geoffroy Venton, Xavier Thomas, Emmanuel Raffoux, Arnaud Pigneux, Thomas Cluzeau, Judith Desoutter, Julie Gay, Claude Preudhomme, Pierre Fenaux, Lionel Adès

    Published in Haematologica (2018-10-01)
    Get full text
    Article


  8. 8

    New Short Tandem Repeat-Based Molecular Typing Method for Pneumocystis jirovecii Reveals Intrahospital Transmission between Patients from Different Wards. by Maud Gits-Muselli, Marie-Noelle Peraldi, Nathalie de Castro, Véronique Delcey, Jean Menotti, Nicolas Guigue, Samia Hamane, Emmanuel Raffoux, Anne Bergeron, Sandrine Valade, Jean-Michel Molina, Stéphane Bretagne, Alexandre Alanio

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  9. 9

    Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia <i>FL... by Nicolas Vignal, Loïs Kelly, Etienne Lengline, Aurélie Cabannes-Hamy, Justine Siavellis, David Ghez, Hélène Sauvageon, Thorsten Braun, Evelyne Jacqz-Aigrain, Milena Kohn, Philippe Rousselot, Alexandre Puissant, Emmanuel Raffoux, Samia Mourah, Lauriane Goldwirt

    Published in Haematologica (2023-02-01)
    Get full text
    Article


  10. 10

    Persistent BCR::ABL1‐positive preleukemic stem cells drive late clonal evolution in Philadelphia chromosome‐positive ALL by Jean‐Edouard Martin, Julien Cliquot, Rathana Kim, Stéphanie Mathis, Jean‐Michel Cayuela, Marie Passet, Baptiste Gaillard, Chantal Himberlin, André Baruchel, Raphaël Itzykson, Jean Soulier, Nicolas Boissel, Emmanuel Raffoux, Pascale Cornillet‐Lefebvre, Emmanuelle Clappier

    Published in HemaSphere (2026-05-01)
    Get full text
    Article


  11. 11

    Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a repor... by Ramy Rahmé, Lionel Ades, Xavier Thomas, Agnès Guerci-Bresler, Arnaud Pigneux, Norbert Vey, Emmanuel Raffoux, Sylvie Castaigne, Olivier Spertini, Sebastian Wittnebel, Jean Pierre Marolleau, Gandhi Damaj, Dominique Bordessoule, Julie Lejeune, Sylvie Chevret, Pierre Fenaux

    Published in Haematologica (2018-11-01)
    Get full text
    Article


  12. 12

    Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: results from two clinical trials by Richard F. Schlenk, Jürgen Krauter, Emmanuel Raffoux, Karl-Anton Kreuzer, Markus Schaich, Lucien Noens, Thomas Pabst, Madhuri Vusirikala, Didier Bouscary, Andrew Spencer, Anna Candoni, Jorge Sierra Gil, Noah Berkowitz, Hans-Jochen Weber, Oliver Ottmann

    Published in Haematologica (2018-01-01)
    Get full text
    Article


  13. 13

    Mesenchymal stromal cells confer chemoresistance to myeloid leukemia blasts through Side Population functionality and ABC transporter activation by Laetitia Boutin, Pierre Arnautou, Aurélie Trignol, Amandine Ségot, Thomas Farge, Christophe Desterke, Sabrina Soave, Denis Clay, Emmanuel Raffoux, Jean-Emmanuel Sarry, Jean-Valère Malfuson, Jean-Jacques Lataillade, Marie-Caroline Le Bousse-Kerdilès, Adrienne Anginot

    Published in Haematologica (2020-04-01)
    Get full text
    Article


  14. 14

    Prognostic significance of monocytic-like phenotype in patients with AML treated with venetoclax and azacytidine by Lin-Pierre Zhao, Typhaine Dumas-Rivero, Lauren Barette, Lorea Aguinaga, Arij Cheffai, Clémentine Chauvel, Reinaldo Dal Bello, Emmanuel Raffoux, Emmanuelle Clappier, Matthieu Duchmann, Pierre Fenaux, Pierre Lemaire, Stephanie Mathis, Marie Sébert, Lionel Adès, Raphaël Itzykson

    Published in Blood Advances (2025-07-01)
    Get full text
    Article


  15. 15

    Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study by Patrice Chevallier, Francoise Huguet, Emmanuel Raffoux, Anne Etienne, Thibaut Leguay, Francoise Isnard, Nelly Robillard, Thierry Guillaume, Jacques Delaunay, Aude Charbonnier, Arnaud Pigneux, Pierre Peterlin, Marie C. Bené, William A. Wegener, David M. Goldenberg, Hervé Dombret

    Published in Haematologica (2015-04-01)
    Get full text
    Article


  16. 16

    Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia by Pierre Peterlin, Aline Renneville, Raouf Ben Abdelali, Olivier Nibourel, Xavier Thomas, Cécile Pautas, Stéphane de Botton, Emmanuel Raffoux, Jean-Michel Cayuela, Nicolas Boissel, Christine Terré, Karine Celli-Lebras, Sylvie Castaigne, Claude Preudhomme, Claude Gardin, Hervé Dombret

    Published in Haematologica (2015-05-01)
    Get full text
    Article


  17. 17

    Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Fra... by Lionel Ades, Thomas Prebet, Aspasia Stamatoullas, Christian Recher, Romain Guieze, Emmanuel Raffoux, Krimo Bouabdallah, Mathilde Hunault, Eric Wattel, Laure Stalnikiewicz, Andrea Toma, Hervé Dombret, Norbert Vey, Marie Sebert, Claude Gardin, Cendrine Chaffaut, Sylvie Chevret, Pierre Fenaux

    Published in Haematologica (2017-04-01)
    Get full text
    Article


  18. 18

    Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial by Juliette Lambert, Cécile Pautas, Christine Terré, Emmanuel Raffoux, Pascal Turlure, Denis Caillot, Ollivier Legrand, Xavier Thomas, Claude Gardin, Karïn Gogat-Marchant, Stephen D. Rubin, Rebecca J. Benner, Pierre Bousset, Claude Preudhomme, Sylvie Chevret, Herve Dombret, Sylvie Castaigne

    Published in Haematologica (2019-01-01)
    Get full text
    Article


  19. 19

    Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort by Augustin Boudry, Laurène Fenwarth, Raphaël Itzykson, Thorsten Braun, Lionel Adès, Élise Fournier, Céline Berthon, Delphine Lebon, Stéphane De Botton, Régis Peffault de Latour, Cécile Pautas, Hervé Dombret, Emmanuel Raffoux, Claude Gardin, Karine Celli-Lebras, Claude Preudhomme, Nicolas Duployez

    Published in Blood Cancer Journal (2026-05-01)
    Get full text
    Article


  20. 20

    Biological Effects of BET Inhibition by OTX015 (MK-8628) and JQ1 in NPM1-Mutated (NPM1c) Acute Myeloid Leukemia (AML) by Hanane Djamai, Jeannig Berrou, Mélanie Dupont, Marie-Magdelaine Coudé, Marc Delord, Emmanuelle Clappier, Alice Marceau-Renaut, Anna Kaci, Emmanuel Raffoux, Raphaël Itzykson, Caroline Berthier, Hsin-Chieh Wu, Rita Hleihel, Ali Bazarbachi, Hugues de Thé, André Baruchel, Claude Gardin, Hervé Dombret, Thorsten Braun

    Published in Biomedicines (2021-11-01)
    Get full text
    Article


Search Tools: